Key Events This Week
3 Aug: Flat quarterly performance reported amid margin pressures
4 Aug: Downgrade to Strong Sell rating by MarketsMOJO
4 Aug: Technical momentum shifts to sideways with bearish indicators
6 Aug: Further technical deterioration to mildly bearish stance

Astec Lifesciences Ltd Faces Technical Momentum Shift Amid Bearish Signals
2026-08-06 08:02:50Astec Lifesciences Ltd, a micro-cap player in the Pesticides & Agrochemicals sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish stance. Recent technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, reveal a complex picture that investors must carefully analyse amid the stock’s underperformance relative to the broader market.
Read full news article
Astec Lifesciences Downgraded to Strong Sell Amidst Flat Financials and Weak Technicals
2026-08-04 08:21:39Astec Lifesciences Ltd, a micro-cap player in the Pesticides & Agrochemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 3 August 2026. This shift reflects deteriorating financial trends, subdued valuation appeal, weakening technical indicators, and declining overall quality metrics, signalling heightened risk for investors amid challenging market conditions.
Read full news article
Astec Lifesciences Ltd Faces Technical Momentum Shift Amid Bearish Signals
2026-08-04 08:05:27Astec Lifesciences Ltd, a micro-cap player in the Pesticides & Agrochemicals sector, has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bullish to sideways trends. The stock’s recent performance, coupled with deteriorating technical grades and a significant downgrade in its Mojo Grade to Strong Sell, highlights growing investor caution amid bearish pressures.
Read full news article
Astec Lifesciences Ltd is Rated Sell
2026-08-03 10:11:08Astec Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Astec Lifesciences Ltd Reports Flat Quarterly Performance Amid Margin Pressures
2026-08-03 08:00:09Astec Lifesciences Ltd, a micro-cap player in the Pesticides & Agrochemicals sector, has reported a flat financial performance for the quarter ended June 2026, signalling a notable shift from its previously positive growth trajectory. Despite a robust 20.5% growth in net sales over the nine-month period, the company’s quarterly revenue contracted by 8.3%, accompanied by deteriorating operational metrics and a downgrade in its Mojo Grade from Strong Sell to Sell.
Read full news article
Astec LifeSciences Q1 FY27: Losses Deepen as Revenue Slides 8% Amid Agrochemical Sector Headwinds
2026-07-31 20:46:26Astec LifeSciences Ltd., a Mumbai-based manufacturer of agrochemicals and pharmaceutical intermediates, reported a consolidated net loss of ₹18.72 crores for Q1 FY27 ended June 2026, marking a 43.34% deterioration year-on-year compared to a loss of ₹33.04 crores in Q1 FY26. The company's revenue declined 8.26% YoY to ₹83.56 crores, reflecting persistent challenges in the agrochemical sector. The stock closed at ₹657.00 on July 31, 2026, down 27.45% over the past year, significantly underperforming both the Sensex and its sectoral peers.
Read full news article
Astec Lifesciences Ltd is Rated Sell
2026-07-23 10:10:52Astec Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.
Read full news article





